Macrophages and therapeutic resistance in cancer

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Neoplastic cell response to therapy is influenced by tumor microenvironment dynamics, not solely genomic complexity.
• Tumor microenvironment plays a critical role in regulating therapeutic efficacy and patient survival.
• Macrophages are central regulators of tissue homeostasis and tumor microenvironments.

Purpose of the Study:

• To review molecular and cellular pathways through which macrophages mediate therapeutic responses.
• To highlight the potential of targeting macrophage pathways to enhance anti-tumor immunity and improve cancer treatment outcomes.
• To discuss the clinical evaluation of therapeutics that modulate macrophage presence and bioactivity.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of molecular and cellular mechanisms involving macrophages in cancer therapy.
• Synthesis of current research on macrophage-mediated therapeutic responses.

Main Results:

• Macrophages significantly influence the efficacy of cancer therapies.
• Targeting macrophage pathways can bolster anti-tumor immune responses.
• Therapeutics modulating macrophage activity show promise in preclinical models and are under clinical investigation.

Conclusions:

• Macrophages are critical mediators of therapeutic response in cancer.
• Modulating macrophage function presents a promising strategy for improving cancer treatment.
• Further research into macrophage-centric pathways is essential for advancing cancer therapy.